Concepedia
1
Publications
16
Citations
H-Index
2019
Active since
Affiliations
Olatec (United States)(Current)
CL Scribner is an author at Olatec (United States).
Publications per year
2019–2019
P160 The first phase 2A proof-of-concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout
Viola Klück, M. Janssen, Antoaneta Comarniceanu et al. · Annals of the Rheumatic Diseases · 2019 · 16 citations · Full text
Rows per page
1–1 of 1